Activation of multiple ERBB family receptors mediates glioblastoma cancer stem-like cell resistance to EGFR-targeted inhibition. - Wikidata - awgldk - TriplyDB

Activation of multiple ERBB family receptors mediates glioblastoma cancer stem-like cell resistance to EGFR-targeted inhibition.

Activation of multiple ERBB family receptors mediates glioblastoma cancer stem-like cell resistance to EGFR-targeted inhibition.

http://www.wikidata.org/entity/Q36062158

about

Biomarkers for glioma immunotherapy: the next generation EGFR Amplification and Glioblastoma Stem-Like Cells Glioblastoma cancer stem cells: Biomarker and therapeutic advances Fluorescent Cancer-Selective Alkylphosphocholine Analogs for Intraoperative Glioma Detection Epidermal growth factor signaling in transformed cells Current Therapeutic Advances Targeting EGFR and EGFRvIII in Glioblastoma Krüppel-like factor 4 acts as an oncogene in colon cancer stem cell-enriched spheroid cells WNK1-OSR1 kinase-mediated phospho-activation of Na+-K+-2Cl- cotransporter facilitates glioma migration.Upregulation of NHE1 protein expression enables glioblastoma cells to escape TMZ-mediated toxicity via increased H⁺ extrusion, cell migration and survival.Alkylphosphocholine analogs for broad-spectrum cancer imaging and therapy.Delineating the cytogenomic and epigenomic landscapes of glioma stem cell lines Genome-wide shRNA screen revealed integrated mitogenic signaling between dopamine receptor D2 (DRD2) and epidermal growth factor receptor (EGFR) in glioblastoma Combined PDK1 and CHK1 inhibition is required to kill glioblastoma stem-like cells in vitro and in vivo Myelin-forming cell-specific cadherin-19 is a marker for minimally infiltrative glioblastoma stem-like cells.A computational approach to identifying gene-microRNA modules in cancer.Integration of MicroRNA, mRNA, and Protein Expression Data for the Identification of Cancer-Related MicroRNAs.Biological and clinical implications of cancer stem cells in primary brain tumors.Nrdp1S, short variant of Nrdp1, inhibits human glioma progression by increasing Nrdp1-mediated ErbB3 ubiquitination and degradation Differential expression of 2',3'-cyclic-nucleotide 3'-phosphodiesterase and neural lineage markers correlate with glioblastoma xenograft infiltration and patient survival.Identification of stem-like cells and clinical significance of candidate stem cell markers in gastric cancer.Prioritizing cancer-related microRNAs by integrating microRNA and mRNA datasets.The role of EGFR and ErbB family related proteins in the oligodendrocyte specification in germinal niches of the adult mammalian brain.Cancer subclonal genetic architecture as a key to personalized medicine.VE-statin/Egfl7 expression in malignant glioma and its relevant molecular network HMGA2 regulates CD44 expression to promote gastric cancer cell motility and sphere formation.Association of collagen architecture with glioblastoma patient survival.Epidermal growth factor receptor as a therapeutic target in glioblastoma.EGFR signaling and autophagy dependence for growth, survival, and therapy resistance.Antibody-drug conjugates in glioblastoma therapy: the right drugs to the right cells.The effects of tumor treating fields and temozolomide in MGMT expressing and non-expressing patient-derived glioblastoma cells.Phosphoribosylpyrophosphate Synthetase 1 Knockdown Suppresses Tumor Formation of Glioma CD133+ Cells Through Upregulating Cell Apoptosis.Glioma-mediated microglial activation promotes glioma proliferation and migration: roles of Na+/H+ exchanger isoform 1.PTPIP51 levels in glioblastoma cells depend on inhibition of the EGF-receptor.Combination therapy targeting integrins reduces glioblastoma tumor growth through antiangiogenic and direct antitumor activity and leads to activation of the pro-proliferative prolactin pathway.Therapeutic targeting of chemoresistant and recurrent glioblastoma stem cells with a proapoptotic variant of oncolytic herpes simplex virus.Glioma stem cells-derived exosomes promote the angiogenic ability of endothelial cells through miR-21/VEGF signal.Overcoming intratumor heterogeneity of polygenic cancer drug resistance with improved biomarker integration Pharmacological Targeting of the Histone Chaperone Complex FACT Preferentially Eliminates Glioblastoma Stem Cells and Prolongs Survival in Preclinical Models microRNA-100 targets SMRT/NCOR2, reduces proliferation, and improves survival in glioblastoma animal models.Fatty acid synthase affects expression of ErbB receptors in epithelial to mesenchymal transition of breast cancer cells and invasive ductal carcinoma.

P2860

Q26825496-AB59A3F1-D4FD-4764-B038-EC090B297AC1 Q26853549-689435EF-7516-42FD-88EC-B95D7EEFB1A4 Q26859782-D77BBCD8-0602-46F7-9C1F-AF07981CFBEB Q27346925-00E23162-0313-44EE-9FD1-26AF21030D44 Q28084034-ED0349AF-E932-4751-959D-6CA0005EADBB Q28087306-D8AA8079-FAF8-4122-80F9-D5357B5A950F Q28486138-6C7860FB-F706-4CF4-B52B-EE2A6A289E82 Q30572906-E26D8976-50AE-412E-B059-C94AD6303FBD Q30586379-F0F7D756-A193-4B81-B188-791A063DD343 Q30620931-93E3F865-E15D-4C93-BC07-A046D0A5012E Q31112229-AB073AFA-75E3-49E7-A839-914D309126DA Q33572296-E8E2F345-314C-4D9F-977E-AA47131F3ABB Q33720256-8FCBE988-5570-4D1B-A8FA-322CDC4E606D Q35112070-8E9AF81A-2604-409D-918F-75FC51EA3492 Q35547227-B041272D-9941-4448-845C-C2194C290ADC Q36240247-21AD74E4-20E7-4A24-BA73-881270918AAB Q36562573-574226E9-65FA-4EE0-B43B-BDF514E29902 Q36595257-77A1B977-4FD3-4C1E-9AA4-DC1D7406FD3D Q36684457-F48343D6-2222-49EA-88C1-FFA9A252308A Q36962804-CEA07282-0FC4-44D7-8C9E-9D8C7E151410 Q37335617-01C34E9D-FD33-447E-B6F1-B799B1BBAF58 Q37397740-D32922CB-6565-47C6-B68C-4423371F110F Q37448116-EED1F417-1B19-4FB7-9C6C-F1A6CA20509B Q37676750-AE6C9518-EC9E-43C4-8A91-B8BB7C7D9397 Q37679995-FF56A975-BFBA-4DB7-BCB6-56CAC188A621 Q37746387-7A37EE3F-F3D9-4356-A101-CED04F30A962 Q38098098-2FEDDAB0-D59A-4831-AA99-64A19AA45A61 Q38171032-B03EF115-6286-4486-A3B7-2AAAD47C300B Q38694765-7A16CCAB-C254-43FA-813B-46FAD5FDC453 Q38730119-40253A35-0785-4C4F-B6F6-ECFD29BACD78 Q38762311-3EF91A7B-0AA7-412E-BC58-271EE2E891FA Q38765106-4C0A0862-BD55-4C74-ABEE-BDCEB966806B Q38888799-A0C465AB-6425-4935-A4FB-9608F84D21CE Q39060605-EEEDE62C-A866-48E4-A365-B8A50DE24E63 Q40178043-3FF1F61F-58BA-40A4-9790-AEEF3FFF2630 Q41055983-16E7A36E-00D4-4BB4-9131-150F0039B370 Q41879186-50B7D7BD-A1F5-437C-B973-B61CDD628830 Q42775850-44C257BC-D503-44FD-9E6C-C7D4A8C8FDCF Q42906818-DCB7E78A-6F18-47CE-88B9-B1791CA69DAA Q43912153-079A4559-6A71-466E-8BC0-FC6F20893603

P2860

Activation of multiple ERBB family receptors mediates glioblastoma cancer stem-like cell resistance to EGFR-targeted inhibition.

http://www.wikidata.org/entity/Q36062158

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Activation of multiple ERBB fa ...... e to EGFR-targeted inhibition.

@ast

Activation of multiple ERBB fa ...... e to EGFR-targeted inhibition.

@en

type

label

Activation of multiple ERBB fa ...... e to EGFR-targeted inhibition.

@ast

Activation of multiple ERBB fa ...... e to EGFR-targeted inhibition.

@en

prefLabel

Activation of multiple ERBB fa ...... e to EGFR-targeted inhibition.

@ast

Activation of multiple ERBB fa ...... e to EGFR-targeted inhibition.

@en

P1433

Q36062158-7FB9C3C7-F41C-4E2E-A057-18446B44E4C8

P1476

Q36062158-214C7D18-7561-4227-B0FD-1899B967798D

P2093

Q36062158-0B002D21-C730-4CDA-AC3E-E1AFFA41DF70

Q36062158-2B192416-35C0-4E29-98AC-C073297E28EE

Q36062158-2EC0DBDF-1FB9-4EAA-A928-F09A797D6ECC

Q36062158-416AA5B9-BCC0-4072-90E3-A0D66BB382A8

Q36062158-6FBF9144-25C0-47CA-BFE7-B5E01DDE52F5

Q36062158-7366CE66-3A25-4DB7-BA2D-ED0CB9D1010F

P2860

Q36062158-0ED1461D-75AC-47C5-9D7B-736BB76974F5

Q36062158-1139DC7E-4A0A-45FC-90FD-B014DC4619EE

Q36062158-13E8005C-E722-47E1-9FD0-CEA9A53A08C0

Q36062158-14771DB1-EE3B-44DB-9CA5-E328AE2C7258

Q36062158-1500BAC6-682B-487E-BFCA-B07F2A0EF80A

Q36062158-1E9548C0-7612-420B-929C-9D10F645695E

Q36062158-262C62D9-324B-4217-8BA3-495767BD240D

Q36062158-27717E9B-69BA-49DB-8928-4B4EB6E166C3

Q36062158-35A00C26-173B-44AE-A835-941ADF680A87

Q36062158-37561681-1F02-40A3-8EAD-31F068C3F326

P304

Q36062158-D3DC7ACD-C6B7-4F54-BDE4-F2F8CC15F59B

P31

Q36062158-F6021D9F-F1EE-4137-80F9-83AE10C1EA44

P356

Q36062158-95A2A735-E70A-4155-90D8-12AB2B528850

P433

Q36062158-EA8F3081-3303-4777-B738-0E2331ECCE6B

P478

Q36062158-215CCF71-BD0B-4B0B-9539-B5BED687EBCA

P50

Q36062158-DBED871F-05D0-46B9-98E0-1600119D5603

Q36062158-DF568F32-2785-42C4-8333-B916C22C04ED

P577

Q36062158-7B861C5C-6D30-4F15-99B8-DD897D496F84

P5875

Q36062158-BE9AFB7E-E836-4C25-A18B-30667B3C22C9

P698

Q36062158-6AD5CFA6-DCE2-48B3-8981-CC64A4BA605A

P932

Q36062158-E260599F-B5D3-45D0-8DAE-6139571BEE6F

P356

P1433

P1476

Activation of multiple ERBB fa ...... ce to EGFR-targeted inhibition

@en

P2093

Daniel M Treisman

http://www.w3.org/2001/XMLSchema#string

Deric L Wheeler

http://www.w3.org/2001/XMLSchema#string

Haviryaji Kalluri

http://www.w3.org/2001/XMLSchema#string

Mari Iida

http://www.w3.org/2001/XMLSchema#string

Paul A Clark

http://www.w3.org/2001/XMLSchema#string

Sathyapriya Ezhilan

http://www.w3.org/2001/XMLSchema#string

P2860

Activation of ERBB2 signaling causes resistance to the EGFR-directed therapeutic antibody cetuximab

Comprehensive genomic characterization defines human glioblastoma genes and core pathways

Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors.

Neuregulin-1-mediated autocrine signaling underlies sensitivity to HER2 kinase inhibitors in a subset of human cancers.

Glioma stem cells promote radioresistance by preferential activation of the DNA damage response

Untangling the ErbB signalling network

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

Identification of human brain tumour initiating cells

Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell

Identification of a cancer stem cell in human brain tumors

P304

420-428

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1596/NEO.12432

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P50

Michael Zorniak

P577

2012-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

228089418

http://www.w3.org/2001/XMLSchema#string

P698

22745588

http://www.w3.org/2001/XMLSchema#string

P932

3384429

http://www.w3.org/2001/XMLSchema#string